Botox Versus Tacrolimus in Psoriasis Vulgaris

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

October 31, 2026

Conditions
Psoriasis Vulgaris
Interventions
DRUG

Botulinum Toxin-A

Botulinum Toxin-A (BoNT-A) is an injectable neuromodulator produced by Clostridium Botulinum, a Gram-positive bacillus that causes Botulism.

DRUG

Tacrolimus

topical Calcineurin inhibitor

All Listed Sponsors
lead

Assiut University

OTHER

NCT06203470 - Botox Versus Tacrolimus in Psoriasis Vulgaris | Biotech Hunter | Biotech Hunter